Internationale ME/CFS Fachkonferenz 2023

Internationale „ME/CFS Conference 2023 – Understand, Diagnose, Treat“ des Charité Fatigue Center, Berlin
Am 11./12. Mai 2023 haben sich international führende ME/CFS Expert*innen über den Stand der Forschung ausgetauscht. Wir veröffentlichen hier alle Vorträge der Konferenz von und für Wissenschaftler*innen und Kliniker*innen (auf Englisch) sowie Zusammenfassungen der Vorträge (auf Deutsch), die zusammen mit der Deutschen Gesellschaft für ME/CFS (Danke!) erstellt wurden.

Hier die Konferenz Ankündigung nachlesen.  Bitte unterstützen Sie auch unsere Arbeit!

Logo_Charite.svg

unterstützt von:

mecfs-logo
Weidenhammer+Zöbele+Stiftung+Logo-640w

Day 1 - 09:00 h

Welcome - ME/CFS Conference 2023

Carmen Scheibenbogen, Charité Fatigue Center, Berlin, Germany  

ME/CFS and Post-COVID Syndrome (PCS) I

Day 1 - 09:05 h

Autoimmunity to the Autonomic Nervous System: The Mechanism to Many Common Clinical Conditions (Keynote)

Yehuda Shoenfeld, Tel Aviv University, Israel  

Day 1 - 09:35 h

ME/CFS as Part of the PCS Spectrum

Carmen Scheibenbogen, Charité Fatigue Center, Berlin, Germany  

Diagnosis I

Day 1 - 10:00 h

Diagnosing ME/CFS – State of the Art

Day 1 - 10:20 h

Autonomic Dysfunction in ME/CFS

This Video will be made available when the speaker authorises its publication.

Day 1 - 10:40 h

Breathing and Muscular Dysfunction in ME/CFS

Diagnosis II

Day 1 - 11:40 h

Brain Fog and Neurocognitive Assessment in ME/CFS

Day 1 - 11:55 h

Sleep Disturbance in ME/CFS

Day 1 - 12:10 h

Hypermobility in ME/CFS

Poster Talks (3 min. overview of select posters)

Day 1 - 12:30 h

Poster Presentation: blood cell deformability cytometry

Day 1 - 12:34 h

Poster Presentation: COVID-19 - the ultimate nfkB rush and the crucial importance of nicotinic acetylcholine receptors

Day 1 - 12:38 h

Poster Presentation: Developing a blood cell-based diagnostic test for ME/CFS, using peripheral blood mononuclear cells

Karl J. Morten, University of Oxford, UK

Day 1 - 12:42 h

Poster Presentation: Changes of the gut microbiome in CFS Patients in response to whole-body Cryotherapy

Sorry, the video of this presentation is not available, as the speaker did not authorise its publication yet. Video and presentation (PDF) may be published at a later date, once the presented data has been published.

Day 1 - 12:46 h

Poster Presentation: Blood immune cells of post COVID-19 syndrome patients present with distinct alterations in their transcriptional states

Charlotte Kröger, University of Bonn, Germany

Day 1 - 12:50 h

Poster Presentation: Skeletal muscle abnormalities contribute to post-exertional malaise in Long COVID

Day 1 - 12:54 h

Poster presentation: Effects of serum factors in patents with ME/CFS after COVID-19 on endothelial cell function in vitro

Day 1 - 12:58 h

Poster Presentation: Symptom persistence and biomarkers in post-COVID-19/chronic fatigue syndrome

Franziska Legler, Charité University Medicine, Berlin, Germany

Understanding I

Day 1 - 14:00 h

Assessing Endothelial Dysfunction

This Video will be made available when the speaker authorises its publication.

Day 1 - 14:15 h

Optical Coherence Tomography Angiography and Cell Deformability in ME/CFS

Bettina Hohberger, University of Erlangen, Germany

Day 1 - 14:30 h

Novel Biomarkers of Endothelial Dysfunction and Angiogenesis Alterations in PCS and ME/CFS

Day 1 - 14:45 h

Understanding Post-Exertional Malaise (PEM)

Christian Puta, University of Jena, Germany

ME/CFS and PCS II

Day 1 - 15:00 h

Insights from ME/CFS May Help Unravel the Pathogenesis of PCS

Anthony L. Komaroff, Harvard Medical School, USA

Day 1 - 15:20 h

Predictors of ME/CFS following EBV and implications for PCS

Understanding II

Sorry, the video of this presentation is not available, as the speaker did not authorise its publication yet. Video and presentation (PDF) may be published at a later date, once the presented data has been published.

Day 1 - 16:20 h

Immune Signature of ME/CFS

Anna Aschenbrenner, DZNE, Bonn, Germany

Sorry, the video of this presentation is not available. The speaker did not authorise its publication.

Day 1 - 16:40 h

Autoantibodies to Glial Cells

Andreas Goebel, University of Liverpool, UK

Day 1 - 16:55 h

EBV Mimicry in ME/CFS

Day 1 - 17:10 h

Mitochondrial Dysfunction and Herpesviruses in ME/CFS

Treatment I

Day 2 - 09:20 h

Multiprofessional Inpatient ME/CFS Treatment

Day 2 - 09:35 h

Neuromodulation in ME/CFS

Day 2 - 09:55 h

Medical Care Situation and Stigma with ME/CFS

Day 2 - 10:10 h

Psychological Support in ME/CFS

Treatment II

This Video will be made available when the speaker authorises its publication.

Day 2 - 11:00 h

B and Plasma Cell Targeting in ME/CFS

Sorry, the video of this presentation is not available. The speaker did not authorise its publication.

Day 2 - 11:20 h

Immunoadsorption in Severly Affected ME/CFS Patients

Day 2 - 11:40 h

Immunoadsorption in PCS and ME/CFS

Day 2 - 11:55 h

Treating Orthostatic Intolerance in ME/CFS

Day 2 - 12:10 h

Vascular Targeting in ME/CFS

Klaus Wirth, University of Frankfurt / Mitodicure GmbH, Germany

de_DEGerman